Evidence map›Paper›PMID 21932040›Full record

ArticleJournal of molecular neuroscience : MN2012

Effect of sodium valproate administration on brain neprilysin expression and memory in rats.

Natalia N Nalivaeva, Nikolai D Belyaev, David I Lewis, Alasdair R Pickles, Natalia Z Makova, Daria I Bagrova, Nadezhda M Dubrovskaya, Svetlana A Plesneva, Igor A Zhuravin, Anthony J Turner

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Bone Marrow-Derived Mesenchymal Stem Cells andStem cells international · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Glucocorticoid-Dependent Mechanisms of Brain Tolerance to Hypoxia.International journal of molecular sciences · 2021
    Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Natalia N NalivaevaInstitute of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, LS2 9JT, United Kingdom. n.n.nalivaeva@leeds.ac.uk
Nikolai D Belyaev
David I Lewis
Alasdair R Pickles
Natalia Z Makova
Daria I Bagrova
Nadezhda M Dubrovskaya
Svetlana A Plesneva
Igor A Zhuravin
Anthony J Turner
Institute of Evolutionary Physiology and Biochemistry · RUUniversity of Leeds · GB

Funding

Medical Research Council G0802189
6 · The paper itself

Abstract

Alzheimer's disease (AD) is accompanied by memory loss due to neuronal cell death caused by toxic amyloid β-peptide (Aβ) aggregates. In the healthy brain, a group of amyloid-degrading enzymes including neprilysin (NEP) maintain Aβ levels at physiologically low concentrations but, with age and under some pathological conditions, expression and activity of these enzymes decline predisposing to late-onset AD. Hence, up-regulation of NEP might be a viable strategy for prevention of Aβ accumulation and development of the disease. As we have recently shown, inhibitors of histone deacetylases, in particular, valproic acid (VA), were capable of up-regulating NEP expression and activity in human neuroblastoma SH-SY5Y cell lines characterised by very low levels of NEP. In the present study, analysing the effect of i.p. injections of VA to rats, we have observed up-regulation of expression and activity of NEP in rat brain structures, in particular, in the hippocampus. This effect was brain region- and age-specific. Administration of VA has also restored NEP activity and memory deficit in adult rats caused by prenatal hypoxia. This suggests that VA and more specific HDAC inhibitors can be considered as potential pharmaceutical agents for up-regulation of NEP activity and improvement of cognitive functions of ageing brain.

Indexed as

Alzheimer DiseaseAnimalsAnticonvulsantsCell Line, TumorDisease Models, AnimalFemaleHumansMaleMemoryMemory DisordersNeprilysinNeuroblastomaRatsRats, WistarValproic AcidAnticonvulsantsNeprilysinValproic Acid

Identifiers

PMID21932040
OpenAlexW2083103946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.